Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Antiproliferative activity from Aldama arenaria (Baker) E. E. Schill. & Panero

Full text
Author(s):
de Oliveira, Adriana da S. S. [1, 2, 3] ; Imamura, Paulo M. [2] ; Ruiz, Ana L. T. G. [3] ; Appezzato-da-Gloria, Beatriz [4] ; de Oliveira, Tuane [1] ; Garcia, Vera L. [1, 3]
Total Authors: 6
Affiliation:
[1] Univ Estadual Campinas, Inst Biol, Campinas, SP - Brazil
[2] Univ Estadual Campinas, Inst Quim, Campinas, SP - Brazil
[3] Univ Estadual Campinas, Ctr Pluridisciplinar Pesquisas Quim Biol & Agr, Paulinia, SP - Brazil
[4] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz ESALQ, Piracicaba, SP - Brazil
Total Affiliations: 4
Document type: Journal article
Source: Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas; v. 20, n. 1, p. 51-60, JAN 2021.
Web of Science Citations: 0
Abstract

Chloroform extract (CE) and fractions obtained from Aldama arenaria roots were evaluated for their in vitro antiproliferative activity against 10 human tumor cell lines {[}leukemia (K-562), breast (MCF-7), ovary expressing a multidrug-resistant phenotype (NCI/ADR-RES), melanoma (UACC-62), lung (NCI-H460), prostate (PC-3), colon (HT29), ovary (OVCAR-3), glioma (U251), and kidney (786-0)]. CE presented weak to moderate antiproliferative activity (mean log GI(50) 1.07), whereas fractions 3 and 4, enriched with pimarane-type diterpenes {[}ent-pimara-8(14),15-dien-19-oic acid and ent-8(14),15-pimaradien-3 beta-ol], presented moderate to potent activity for most cell lines, with mean log 0150 of 0.62 and 0.59, respectively. The results showed promising in vitro antiproliferative action of the samples obtained from A. arenaria, with the best results for NCI/ADR-RES, HT29, and OVCAR-3, and TGI values ranging from 5.95 to 28.71 mu g.mL-1, demonstrating that compounds of this class may be potential prototypes for the discovery of new therapeutic agents. (AU)

FAPESP's process: 10/51454-3 - Morphoanatomical, metabolomic and molecular studies as subsidies to the systematic of Asteraceae species and access to their pharmacological potential
Grantee:Beatriz Appezzato da Glória
Support type: Research Projects - Thematic Grants